QA: Clene Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001822791_2023_Clene_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001822791, Clene Inc

  xvar xval
0 AssetsCurrent 29,195,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 15,298,000
4 LiabilitiesCurrent 13,857,000
5 LiabilitiesNoncurrent 5,557,000
6 remainder_Liabilities 21,842,000
7 CostOfGoodsAndServicesSold 26,000
8 SellingGeneralAndAdministrativeExpense 16,936,000
9 ResearchAndDevelopmentExpense 31,920,000
10 remainder_Expenses 0
11 remainder_Revenues 473,000
12 remainder_NetIncome 18,491,000
13 remainder_ComprehensiveNetIncome -30,000
  yvar yval
0 Assets 44,493,000
1 Liabilities 41,256,000
2 Expenses 48,882,000
3 Revenues 473,000
4 StockholdersEquity 3,237,000
5 NetIncome -29,918,000
6 ComprehensiveNetIncome -29,933,000
7 BaseVar 76,812,500
8 EconomicCapitalRatiobeforeLimitedLiability -0.534
9 EconomicCapitalRatio 1.38

Edgar->Model Mapping

Feature Distribution